ikfe-CRO GmbH
Quick facts
Marketed products
- Metformin and Saxagliptin · Diabetes
Metformin reduces hepatic glucose production and improves insulin sensitivity, while saxagliptin inhibits DPP-4 to increase incretin-mediated insulin secretion and reduce glucagon.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: